Search Results

You are looking at 1 - 3 of 3 items for

  • Author: Bo Yang x
Clear All Modify Search
Mengxue Yang Department of Endocrinology, The Fifth People’s Hospital of Shanghai, Fudan University, Shanghai, China
Department of Endocrinology, Zunyi Medical University, Zunyi, China

Search for other papers by Mengxue Yang in
Google Scholar
PubMed
Close
,
Bowen Sun Department of Endocrinology, Zunyi Medical University, Zunyi, China

Search for other papers by Bowen Sun in
Google Scholar
PubMed
Close
,
Jianhui Li Department of Endocrinology, Ningbo No. 2 Hospital, Ningbo, China

Search for other papers by Jianhui Li in
Google Scholar
PubMed
Close
,
Bo Yang Department of Endocrinology, Zunyi Medical University, Zunyi, China

Search for other papers by Bo Yang in
Google Scholar
PubMed
Close
,
Jie Xu School of Public Health, Zunyi Medical University, Zunyi, China

Search for other papers by Jie Xu in
Google Scholar
PubMed
Close
,
Xue Zhou Department of Endocrinology, Zunyi Medical University, Zunyi, China

Search for other papers by Xue Zhou in
Google Scholar
PubMed
Close
,
Jie Yu School of Public Health, Zunyi Medical University, Zunyi, China

Search for other papers by Jie Yu in
Google Scholar
PubMed
Close
,
Xuan Zhang Department of Endocrinology, Zunyi Medical University, Zunyi, China

Search for other papers by Xuan Zhang in
Google Scholar
PubMed
Close
,
Qun Zhang Department of Endocrinology, Ningbo No. 2 Hospital, Ningbo, China

Search for other papers by Qun Zhang in
Google Scholar
PubMed
Close
,
Shan Zhou Department of Endocrinology, Ningbo No. 2 Hospital, Ningbo, China

Search for other papers by Shan Zhou in
Google Scholar
PubMed
Close
, and
Xiaohua Sun Department of Endocrinology, Ningbo No. 2 Hospital, Ningbo, China

Search for other papers by Xiaohua Sun in
Google Scholar
PubMed
Close

Objectives

The pathogenesis of Graves’ disease (GD) remains unclear. In terms of environmental factors, GD development may be associated with chronic inflammation caused by alteration of the intestinal flora. This study explored the association of intestinal flora alteration with the development of GD among the Han population in southwest China.

Design and methods

Fifteen GD patients at the Affiliated Hospital of Zunyi Medical College between March 2016 and March 2017 were randomly enrolled. Additionally, 15 sex- and age-matched healthy volunteers were selected as the control group during the same period. Fresh stool samples were collected, and bacterial 16S RNA was extracted and amplified for gene sequencing with the Illumina MiSeq platform. The sequencing results were subjected to operational taxonomic unit-based classification, classification verification, alpha diversity analysis, taxonomic composition analysis and partial least squares-discriminant analysis (PLS-DA).

Results

The diversity indices for the GD group were lower than those for the control group. The GD group showed significantly higher abundances of Firmicutes, Proteobacteria and Actinobacillus and a higher Firmicutes/Bacteroidetes ratio than the control group. PLS-DA suggested the satisfactory classification of the flora between the GD group and the control group. The abundances of the genera Oribacterium, Mogibacterium, Lactobacillus, Aggregatibacter and Mogibacterium were significantly higher in the GD group than in the control group (P < 0.05).

Conclusions

The intestinal flora of GD patients was significantly different from that of the healthy population. Thus, alteration of intestinal flora may be associated with the development of GD.

Open access
Xingyao Tang Beijing Tongren Hospital, Capital Medical University

Search for other papers by Xingyao Tang in
Google Scholar
PubMed
Close
,
Zhi-Hui Song Department of Pharmacy, Beijing Tongren Hospital, Capital Medical University, Beijing, China

Search for other papers by Zhi-Hui Song in
Google Scholar
PubMed
Close
,
Dawei Wang General Practice Department, Beijing Tongren Hospital, Capital Medical University, Beijing, China

Search for other papers by Dawei Wang in
Google Scholar
PubMed
Close
,
Jinkui Yang Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University, Beijing, China

Search for other papers by Jinkui Yang in
Google Scholar
PubMed
Close
,
Marly Augusto Cardoso Department of Nutrition, School of Public Health, University of Sao Paulo, Sao Paulo, Brazil

Search for other papers by Marly Augusto Cardoso in
Google Scholar
PubMed
Close
,
Jian-Bo Zhou Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University, Beijing, China

Search for other papers by Jian-Bo Zhou in
Google Scholar
PubMed
Close
, and
Rafael Simó Endocrinology and Nutrition Department, Hospital Universitari Vall d’Hebron, Diabetes and Metabolism Research Unit, Vall d’Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain

Search for other papers by Rafael Simó in
Google Scholar
PubMed
Close

Thyroid hormone, as a modifiable risk factor for dementia, promotes neurocognitive function and regulates metabolic processes. Various studies have defined different thyroid-stimulating hormone cutoffs, but the safest thyroid-stimulating hormone concentration was absent. A dose–response meta-analysis describing the overall functional relation and identifying exposure intervals associated with a higher or lower disease risk is thus desirable. Therefore, our current analysis was conducted to understand the influence of thyroid dysfunction on dementia risk. We searched PubMed, Embase, and Web of Science before May 1, 2020 for human studies published in English. Studies were considered for inclusion if they used a cohort study design to measure the risk of dementia in different thyroid function status groups, diagnosed thyroid functional status and all-cause dementia, included participants aged >18 years, and provided quantitative measures of data. The analysis contained 17 articles with 344,248 individuals with a 7.8-year mean follow-up. Ten studies with 329,287 participants indicated that only subclinical hyperthyroidism was associated with an increased risk of dementia. In contrast, subclinical hypothyroidism, clinical hyperthyroidism, and clinical hypothyroidism did not affect dementia. In the dose–response meta-analysis with 46,417 samples from 11 studies, the association of thyroid-stimulating hormone with the risk of dementia exhibited a U-shaped curve. Our study indicated that subclinical hyperthyroidism was associated with the risk of dementia and the thyroid-stimulating hormone concentration at around 1.55–1.60 mU/L as the optimum range for the risk of dementia.

Open access
Min Yang Graduate School, Beijing University of Chinese Medicine, Beijing, China
Department of Pediatrics, China-Japan Friendship Hospital, Beijing, China

Search for other papers by Min Yang in
Google Scholar
PubMed
Close
,
Xiangling Deng Graduate School, Beijing University of Chinese Medicine, Beijing, China
Department of Pediatrics, China-Japan Friendship Hospital, Beijing, China

Search for other papers by Xiangling Deng in
Google Scholar
PubMed
Close
,
Shunan Wang Graduate School, Beijing University of Chinese Medicine, Beijing, China
Department of Pediatrics, China-Japan Friendship Hospital, Beijing, China

Search for other papers by Shunan Wang in
Google Scholar
PubMed
Close
,
Bo Zhou Graduate School, Beijing University of Chinese Medicine, Beijing, China
Department of Pediatrics, China-Japan Friendship Hospital, Beijing, China

Search for other papers by Bo Zhou in
Google Scholar
PubMed
Close
,
Wenquan Niu Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing, China

Search for other papers by Wenquan Niu in
Google Scholar
PubMed
Close
, and
Zhixin Zhang International Medical Services, China-Japan Friendship Hospital, Beijing, China
Department of Pediatrics, China-Japan Friendship Hospital, Beijing, China

Search for other papers by Zhixin Zhang in
Google Scholar
PubMed
Close

Objectives

We aimed to identify and characterize potential factors, both individually and jointly as a nomogram, associated with short stature and pre-shortness in Chinese preschool-aged children.

Methods

Total of 9501 children aged 3–6 years were recruited from 30 kindergartens in Beijing and Tangshan from September to December 2020 using a stratified random sampling method. Effect-size estimates are expressed as odds ratio (OR) and 95% CI.

Results

The prevalence of short stature and pre-shortness in preschool-aged children was 3.9% (n = 375) and 13.1% (n = 1616), respectively. Factors simultaneously associated with the significant risk for short stature, pre-shortness and both included BMI, paternal height, maternal height, birth weight, birth height, latter birth order (≥2) and less parental patience to children. Besides, breastfeeding duration (≥12 months) was exclusively associated with pre-shortness (OR, 95% CI, P: 1.16, 1.01 to 1.33, 0.037), and childhood obesity with both short stature (3.45, 2.62 to 4.54, <0.001) and short stature/pre-shortness (1.37, 1.15 to 1.64, <0.001). Modeling of significant factors in nomograms had descent prediction accuracies, with the C-index being 77.0, 70.1 and 71.2% for short stature, pre-shortness and both, respectively (all P < 0.001).

Conclusions

Our findings indicate the joint contribution of inherited characteristics, nutrition status from the uterus to childhood, and family psychological environment to short stature and pre-shortness in Chinese preschool-aged children. Further validation in other independent groups is warranted.

Open access